Article Information
History
- March 30, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Mary E. Petrone1,2,11,*,
- Carolina Lucas3,11,
- Bridget Menasche4,11,
- Mallery I. Breban1,
- Inci Yildirim1,5,6,
- Melissa Campbell7,
- Saad B. Omer1,6,7,
- Albert I. Ko1,7,
- Nathan D. Grubaugh1,8,
- Akiko Iwasak3,9,
- Craig B. Wilen3,4,
- Chantal B.F. Vogels1,12 and
- Joseph R. Fauver1,10,12,*
- 1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
- 2School of Life and Environmental Sciences, University of Sydney, Sydney, NSW, Australia
- 3Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
- 4Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT, USA
- 5Department of Pediatric, Section of Infectious Diseases and Global Health, Yale University School of Medicine, New Haven, CT, USA
- 6Yale Institute for Global Health, Yale University, New Haven, CT, USA
- 7Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA
- 8Department of Ecology and Evolutionary Biology, Yale University, New Haven, CT, USA
- 9Howard Hughes Medical Institute, Chevy Chase, MD, USA
- 10College of Public Health, University of Nebraska Medical Center, Omaha, NE, USA
- ↵*Corresponding authors. email: jfauver{at}unmc.edu
Posted March 30, 2022.
Insights into the limited global spread of the immune evasive SARS-CoV-2 variant Mu
